Company Overview and News

 
NZ shares surge to record as market reopens

2018-08-29 nzherald.co.nz
New Zealand shares surged to a record as the market reopened after yesterday's platform failure. Synlait Milk and A2 Milk Co led the gains.
CEN FBU WBC FCREY ZNRGF WEBNF WBK FRCEF ZEL COENY COENF SKT ZNZ GNE SYKWF WBC FBU CEN SNZ SKKTY GNE GEL SML

 
NZ shares gain as investors take stock in earnings season

2018-08-17 nzherald.co.nz
New Zealand shares rose as investors took stock in a brief lull to the domestic corporate earnings season, with Skellerup Holdings extending yesterday's gain to break a new record.
CEN AIR NZTCF RYM ACKDF ANZFY AUKNY AIZ COENF GNE AOTUF SKC PPSHY CEN SNZ SKL GEL AIA RHCGF SPKKY NZTCY SPK COENY AIA THL ANZLY RYHTY SKLUY ANZFF GNE MEZ

 
Summerset Group Holdings Ltd, Wellington 2018 Q2 - Results - Earnings Call Slides

2018-08-14 seekingalpha
The following slide deck was published by Summerset Group Holdings Ltd, Wellington in conjunction with their 2018 Q2 earnings call.
SMGRF SNZ

 
NZ shares bounce back led by Synlait Milk

2018-08-14 nzherald.co.nz
New Zealand shares bounced back from some of yesterday's sell-off as investors are yet to see serious contagion from Turkey's burgeoning financial crisis, led higher by Synlait Milk and A2 Milk Co. Summerset Group Holdings fell after reporting first-half earnings.
AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ SKT SYKWF SKKTY SNZ SML AIA FBU SPKKY NZTCY SPK FRCEF PGW KWIPF PGWFY AIA FBU ANZLY ANZFF PGWFF MEZ PFGTF

 
NZ shares fall as Pushpay, Fletcher drop

2018-08-07 nzherald.co.nz
New Zealand shares fell, led lower by ongoing weakness in Pushpay Holdings and as construction sector fears weigh on Fletcher Building, while Summerset Group Holdings gained.
FBU SKC FBU PPSHY FCREY SNZ FRCEF KWIPF

 
NZ shares lift as Synlait rallies on A2 stake lift

2018-08-03 nzherald.co.nz
New Zealand shares gained, led higher by Synlait Milk as A2 lifted its stake in the company while Freightways and Ebos fell.
KTHDY BGR EBOSF THL PPSHY EBOSY SNZ KMD EBO EBO SML KMD

26
NZ shares taper off in strong June quarter

2018-06-29 nzherald.co.nz
New Zealand shares ran out of puff in the final day of the June quarter, which has been the strongest quarterly performance in more than two years. Summerset Group Holdings and Ebos Group declined and Westpac Banking Corp gained.
SGM FCREY NZTCF SMSMY ACKDF AUKNY FTRRF KMD SMUPF AOTUF SNZ KMD SML KTHDY AIA FBU WBC SCY SPKKY NZTCY EBOSY SPK WEBNF WBK FRCEF EBO EBOSF AIA WBC FBU EBO

17
NZ shares rebound, led by Precinct Properties

2018-06-20 nzherald.co.nz
New Zealand shares rebounded from yesterday's 1.2 percent loss, led higher by Precinct Properties New Zealand and Westpac Banking Corp.
WBC SPKKY NZTCY SPK NZTCF WEBNF WBK SKT GNE AOTUF SYKWF WBC PPSHY SNZ SKKTY GNE GEL SML

8
NZ shares up led by Comvita, Summerset

2018-06-13 nzherald.co.nz
New Zealand shares gained to a new record, led higher by Comvita and Summerset Group Holdings, and offsetting the drag of a weaker A2 Milk.
TME TRMEF WBC WBC TME SNZ WEBNF TDMEY WBK

13
NZ shares dip in market lull during US-North Korea summit

2018-06-12 nzherald.co.nz
New Zealand shares dipped in light trading as some stocks gave up dividends, with the focus on the US-North Korea summit in Singapore.
KTHDY SKT SYKWF RHCGF THL RYHTY SNZ SKKTY RYM KMD SML KMD

20
A2 tumbles, dragging down stock index

2018-05-16 nzherald.co.nz
New Zealand shares fell as A2 Milk Co disappointed investors with a market update, dragging down partner Synlait Milk.
FBU RHCGF FCREY SPKKY NZTCY SPK NZTCF RYM FRCEF SKT SYKWF FBU RYHTY VTHPF SNZ SKKTY SML

5
Summerset Group: Secular Growth And Lower Spending Support Long-Term Upside

2018-04-20 seekingalpha
Valuing SMGRF can be tricky due to significant differences between the income and cash flow statements.
SMGRF RHCGF RYHTY SNZ RYM

5
Summerset Group: Secular Growth And Lower Spending Supports Long-Term Upside

2018-04-20 seekingalpha
Valuing SMGRF can be tricky due to significant differences between the income and cash flow statements.
SMGRF RHCGF RYHTY SNZ RYM

29
Shares fall as investors weight up Fletcher rights issue

2018-04-17 nzherald.co.nz
New Zealand shares fell as investors weighed up the impact of Fletcher Building's deeply discounted rights issue soaking up demand from the broader market. Auckland International Airport and exporters A2 Milk Co and Comvita dropped.
CEN FCREY ZNRGF NZTCF RYM ACKDF AUKNY COENF ZNZ GNE ALF CEN SNZ GEL AIA FBU RTBRF SCY RHCGF SPKKY NZTCY SPK ZEL FRCEF PGW COENY PGWFY RTRBY AIA FBU RYHTY RBD GNE PGWFF MEZ

8
NZ shares up, Sky TV bounces with Comvita

2018-04-06 nzherald.co.nz
New Zealand shares gained, led by Sky Network Television bouncing back and Orion Health surging 20 per cent after it confirmed it's considering sale options.
SKT TME TRMEF SYKWF THL TME SNZ SKKTY TDMEY SML

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...